Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li-Qiang Sun

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Journal of Medicinal Chemistry|May 14, 2004
Synthesis and structure-activity relationship of acrylamides as KCNQ2 potassium channel openersYong-Jin Wu, Huan He, Li-Qiang Sun, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2004
(S,E)-N-[1-(3-heteroarylphenyl)ethyl]-3-(2-fluorophenyl)acrylamides: synthesis and KCNQ2 potassium channel opener activityAlexandre L'Heureux, Alain Martel, Huan He, et al.
Bioorganic & Medicinal Chemistry Letters|January 17, 2017
Functionalized triazines as potent HCV entry inhibitorsEric S Mull, Li-Qiang Sun, Qian Zhao, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2003
Heterocyclic aminopyrrolidine derivatives as melatoninergic agentsLi-Qiang Sun, Jie Chen, Ronald J Mattson, et al.
Journal of Medicinal Chemistry|August 22, 2003
Fluorine substitution can block CYP3A4 metabolism-dependent inhibition: identification of (S)-N-[1-(4-fluoro-3- morpholin-4-ylphenyl)ethyl]-3- (4-fluorophenyl)acrylamide as an orally bioavailable KCNQ2 opener devoid of CYP3A4 metabolism-dependent inhibitionYong-Jin Wu, Carl D Davis, Steven Dworetzky, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2004
(S)-N-[1-(4-cyclopropylmethyl-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl)-ethyl]-3-(2-fluoro-phenyl)-acrylamide is a potent and efficacious KCNQ2 opener which inhibits induced hyperexcitability of rat hippocampal neuronsYong-Jin Wu, Christopher G Boissard, Jie Chen, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2012
Preclinical Profile and Characterization of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir (BMS-650032)Fiona McPhee, Amy K Sheaffer, Jacques Friborg, et al.
Bioorganic & Medicinal Chemistry Letters|December 25, 2016
Structure-activity relationships of 4-hydroxy-4-biaryl-proline acylsulfonamide tripeptides: A series of potent NS3 protease inhibitors for the treatment of hepatitis C virusAlan Xiangdong Wang, Jie Chen, Qian Zhao, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2004
Synthesis and KCNQ2 opener activity of N-(1-benzo[1,3]dioxol-5-yl-ethyl, N-[1-(2,3-dihydro-benzofuran-5-yl)-ethyl, and N-[1-(2,3-dihydro-1H-indol-5-yl)-ethyl acrylamidesYong-Jin Wu, Li-Qiang Sun, Huan He, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 2018
P3-P4 ureas and reverse carbamates as potent HCV NS3 protease inhibitors: Effective transposition of the P4 hydrogen bond donorBrian L Venables, Ny Sin, Alan Xiangdong Wang, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Journal of Medicinal Chemistry|May 14, 2004
Synthesis and structure-activity relationship of acrylamides as KCNQ2 potassium channel openersYong-Jin Wu, Huan He, Li-Qiang Sun, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2004
(S,E)-N-[1-(3-heteroarylphenyl)ethyl]-3-(2-fluorophenyl)acrylamides: synthesis and KCNQ2 potassium channel opener activityAlexandre L'Heureux, Alain Martel, Huan He, et al.
Bioorganic & Medicinal Chemistry Letters|January 17, 2017
Functionalized triazines as potent HCV entry inhibitorsEric S Mull, Li-Qiang Sun, Qian Zhao, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2003
Heterocyclic aminopyrrolidine derivatives as melatoninergic agentsLi-Qiang Sun, Jie Chen, Ronald J Mattson, et al.
Journal of Medicinal Chemistry|August 22, 2003
Fluorine substitution can block CYP3A4 metabolism-dependent inhibition: identification of (S)-N-[1-(4-fluoro-3- morpholin-4-ylphenyl)ethyl]-3- (4-fluorophenyl)acrylamide as an orally bioavailable KCNQ2 opener devoid of CYP3A4 metabolism-dependent inhibitionYong-Jin Wu, Carl D Davis, Steven Dworetzky, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2004
(S)-N-[1-(4-cyclopropylmethyl-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl)-ethyl]-3-(2-fluoro-phenyl)-acrylamide is a potent and efficacious KCNQ2 opener which inhibits induced hyperexcitability of rat hippocampal neuronsYong-Jin Wu, Christopher G Boissard, Jie Chen, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2012
Preclinical Profile and Characterization of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir (BMS-650032)Fiona McPhee, Amy K Sheaffer, Jacques Friborg, et al.
Bioorganic & Medicinal Chemistry Letters|December 25, 2016
Structure-activity relationships of 4-hydroxy-4-biaryl-proline acylsulfonamide tripeptides: A series of potent NS3 protease inhibitors for the treatment of hepatitis C virusAlan Xiangdong Wang, Jie Chen, Qian Zhao, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2004
Synthesis and KCNQ2 opener activity of N-(1-benzo[1,3]dioxol-5-yl-ethyl, N-[1-(2,3-dihydro-benzofuran-5-yl)-ethyl, and N-[1-(2,3-dihydro-1H-indol-5-yl)-ethyl acrylamidesYong-Jin Wu, Li-Qiang Sun, Huan He, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 2018
P3-P4 ureas and reverse carbamates as potent HCV NS3 protease inhibitors: Effective transposition of the P4 hydrogen bond donorBrian L Venables, Ny Sin, Alan Xiangdong Wang, et al.
Pageof 3